Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing 210008, China.
School of Stomatology, Zunyi Medical University, Zunyi 563099, China.
Int Immunopharmacol. 2024 Aug 20;137:112522. doi: 10.1016/j.intimp.2024.112522. Epub 2024 Jun 21.
Periodontitis is a common oral disease with high prevalence worldwide. Neural epidermal growth factor-like 1 protein (Nell-1) has recently been reported to have anti-inflammation effects and may be a drug candidate for osteoarthritis. However, its immunotherapeutic effects in periodontitis remain unknown. Therefore, this study aimed to investigate the effects of Nell-1 on periodontitis in terms of macrophage polarization and analyze its possible underlying mechanism.
A rat ligation-induced experimental periodontitis model was established and locally injected with Nell-1 (n = 6/group). Periodontal tissue destruction and macrophage polarization in vivo were analyzed using micro-CT, histology analysis, and western blot. Enzyme-linked immunosorbent assay was used to evaluate serum inflammatory cytokines. Then, the RAW 264.7 macrophage cells were treated with lipopolysaccharide (LPS), Nell-1, and the c-Jun N-terminal kinases (JNK) inhibitor (SP600125). RT-PCR, western blot, and flow cytometry were performed to further analyze the effect of Nell-1 on macrophage polarization and the underlying mechanism in vitro.
Local treatment with Nell-1 significantly alleviated the destruction of alveolar bone and fibers in periodontitis, and upregulated the ratio of M2/M1 macrophages in periodontal tissues (P < 0.05). In vitro, Nell-1 at the concentrations of 200 and 500 ng/mL could significantly inhibit the expression of M1-related inflammatory factors in LPS-stimulated macrophages, and increase the expression of M2-related markers, regulating the macrophage phenotype switch into M2 (P < 0.05). The mRNA of JNK and relative protein level of phospho-JNK/JNK were also upregulated by Nell-1 (P < 0.05). Additionally, the JNK inhibitor (SP600125) could reverse the effect of Nell-1 on macrophage polarization (P < 0.05).
Nell-1 could modulate the ratio of M2/M1 macrophages possibly through the JNK/MAPK signaling pathway, subsequently attenuating the inflammation and destruction of periodontal tissues caused by periodontitis.
牙周炎是一种常见的口腔疾病,在全球范围内患病率很高。神经表皮生长因子样 1 蛋白(Nell-1)最近被报道具有抗炎作用,可能成为骨关节炎的药物候选物。然而,其在牙周炎中的免疫治疗作用尚不清楚。因此,本研究旨在探讨 Nell-1 对牙周炎中巨噬细胞极化的影响,并分析其可能的作用机制。
建立大鼠结扎诱导的实验性牙周炎模型,并局部注射 Nell-1(每组 n=6)。通过 micro-CT、组织学分析和 Western blot 分析体内牙周组织破坏和巨噬细胞极化。酶联免疫吸附试验用于评估血清炎症细胞因子。然后,用脂多糖(LPS)、Nell-1 和 c-Jun N 端激酶(JNK)抑制剂(SP600125)处理 RAW 264.7 巨噬细胞。进行 RT-PCR、Western blot 和流式细胞术进一步分析 Nell-1 对体外巨噬细胞极化的影响及其潜在机制。
局部给予 Nell-1 可显著减轻牙周炎中牙槽骨和纤维的破坏,并增加牙周组织中 M2/M1 巨噬细胞的比例(P<0.05)。体外,浓度为 200 和 500 ng/mL 的 Nell-1 可显著抑制 LPS 刺激的巨噬细胞中 M1 相关炎症因子的表达,并增加 M2 相关标志物的表达,调节巨噬细胞表型向 M2 转化(P<0.05)。Nell-1 还上调了 JNK 的 mRNA 和磷酸化 JNK/JNK 的相对蛋白水平(P<0.05)。此外,JNK 抑制剂(SP600125)可逆转 Nell-1 对巨噬细胞极化的作用(P<0.05)。
Nell-1 可能通过 JNK/MAPK 信号通路调节 M2/M1 巨噬细胞的比例,从而减轻牙周炎引起的牙周组织炎症和破坏。